* Indaptus Therapeutics press release [https://seekingalpha.com/pr/20199347-indaptus-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:INDP [https://seekingalpha.com/symbol/INDP]): Q2 GAAP EPS of -$9.09.
* As of June 30, 2025, the Company had cash and cash equivalents of approximately $6.2 million.
MORE ON INDAPTUS THERAPEUTICS
* Indaptus Therapeutics to execute 1-for-28 reverse stock split [https://seekingalpha.com/news/4462053-indaptus-therapeutics-to-execute-1-for-28-reverse-stock-split]
* Indaptus Therapeutics announces sale of $2.3M of convertible notes, warrants [https://seekingalpha.com/news/4457952-indaptus-therapeutics-announces-sale-of-23m-of-convertible-notes-warrants]
* Seeking Alpha’s Quant Rating on Indaptus Therapeutics [https://seekingalpha.com/symbol/INDP/ratings/quant-ratings]
* Historical earnings data for Indaptus Therapeutics [https://seekingalpha.com/symbol/INDP/earnings]
* Financial information for Indaptus Therapeutics [https://seekingalpha.com/symbol/INDP/income-statement]
Indaptus Therapeutics GAAP EPS of -$9.09
Published 2 months ago
Aug 13, 2025 at 5:16 PM
Negative
Auto